IMAGE: Lung squamous cell carcinoma

Breaking News

Public Release: 19-Jun-2013
New England Journal of Medicine
Drug shows surprising efficacy as treatment for chronic leukemia, mantle cell lymphoma
Two clinical studies published online in the New England Journal of Medicine suggest that the novel, targeted agent ibrutinib shows real potential is a safe, effective, treatment for adults with chronic lymphocytic leukemia and for patients with mantle cell lymphoma.
Pharmacyclics, Inc.; Leukemia and Lymphoma Society; NIH/National Cancer Institute; D. Warren Brown Foundation

Contact: Liz Bryan
LBryan@spectrumscience.com
202-955-6222
Ohio State University Medical Center

Public Release: 19-Jun-2013
Nature Communications
Genetics of cervical cancer raise concern about antiviral therapy in some cases
A new understanding of the genetic process that can lead to cervical cancer may help improve diagnosis of potentially dangerous lesions for some women, and also raises a warning flag about the use of anti-viral therapies in certain cases -- suggesting they could actually trigger the cancer they are trying to cure.
National Institutes of Health

Contact: Andrey Morgun
Andriy.morgun@oregonstate.edu
541-737-3424
Oregon State University

Public Release: 19-Jun-2013
New England Journal of Medicine
Ibrutinib continues strong showing against mantle cell lymphoma
In a major international study led by researchers at the University of Texas MD Anderson Cancer Center, the targeted therapy ibrutinib continues to show remarkable promise for the treatment of relapsed or refractory mantle cell lymphoma.

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center

Latest Multimedia

Novelties to Target Immune Pathways in Cancer

Novelties to Target Immune Pathways in Cancer
Giuseppe Curigliano offers an overview on current cancer research focused on T-regulators and T-effectors and opens hopes for future progress studying ways to re-activate the immune system and ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

The Role of Tumor's Microenvironment in Cancer Growth and Progression

The Role of Tumor's Microenvironment in Cancer Growth and Progression
This shows humor-host interaction: how they speak and what they say. Giuseppe Curigliano explains the "dialogue" between the tumor and the microenvironment surrounding it, highlighting the important ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

IMPAKT 2013 -- Translational Research in Breast Cancer: Program Highlights

IMPAKT 2013 -- Translational Research in Breast Cancer: Program Highlights
Heterogeneity of breast cancer; multigene signatures to determine prognosis; biopsying metastases; emerging pathways; new imaging techniques... This and much more awaits you at IMPAKT if you want a ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

  Search News Releases

     

 

 

EurekAlert!